PRESS RELEASE published on 02/08/2024 at 14:30, 1 year 9 months ago Moneyline Sports Announces Kansas City and San Francisco Big Game Day Campaign With Mobile Sports App "Juice Reel" For Promotional Giveaway of MangoRx's Men's Health and Wellness Products Moneyline Sports Inc. partners with Juice Reel for Big Game Day and Football Finale Campaign, offering bettors enhanced sports analytics and data-driven betting insights through the Juice Reel app for iOS and Android Moneyline Sports Inc. Juice Reel Sports Betting App Big Game Day Football Finale Campaign
PRESS RELEASE published on 09/26/2023 at 15:45, 2 years 2 months ago Moneyline Sports Announces UFC Fighter Natan Levy as First Celebrity Athlete and Brand Ambassador
PRESS RELEASE published on 09/20/2023 at 17:15, 2 years 2 months ago Moneyline Sports Inc. Announces Launch of AI-Sports Betting Platform SportstraderAI.com
PRESS RELEASE published on 08/14/2023 at 15:00, 2 years 3 months ago Moneyline Sports Inc. Announces Launch of Reg CF Offering to Raise up to $3 Million With Issuance Express
Published on 12/05/2025 at 02:35, 4 hours 6 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 41 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 36 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 41 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 3 hours 10 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 50 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 15 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 26 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 30 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:14, 12 hours 26 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 12 hours 41 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 12 hours 41 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 56 minutes ago Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 12 hours 56 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
